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ABSTRACT 
A young male with bipolar affective disorder, mania with psychotic features was started on 
lithium therapy. Four days later, he developed an irregular pulse on a lithium level of 0.45 mmol/L. 
An ECG showed multiple unifocal ventricular ectopics. The cardiac arrhythmia disappeared when 
lithium was discountinued. 
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Lithium is well known to cause cardiac 
arrhythmias in toxic doses (Baldessarini,1996). 
However, it has been known to cause cardiac 
conduction abnormalities within the therapeutic 
range, especially in the elderly (Ayd,1995). 
We report here a case of a patient in whom 
therapeutic level of lithium resulted in ventricular 
ectopics which disappeared on discontinuation 
of lithium. 
A 34 years old male was admitted with 
features of a manic episode with psychotic 
features. He had a past history suggestive of a 
similar episode about four years ago. At that 
time, he was treated in a local hospital with 
chlorpromazine, lithium and carbamazepine for 
about 10 days. Following discharge, he remained 
well and discontinued all medication about two 
weeks later. There was no history of substance 
abuse. Other than a history of asthma as a child 
he had no physical complaints. 
At the time of his admission to St. John's, 
his physical examination was unremarkable. 
Initial blood pressure recording was 130/100 mm 
Hg, but subsequent recordings in the ward, done 
regularly over the next one month were normal. 
His pulse rate was regular. Investigations which 
included haemoglobin level, total and differential 
counts, ESR, blood urea, creatinine, electrolytes. 
blood sugar, VDRL, T3, T,, TSH levels and a 
ECG were normal. 
He was started on lorazepam 2 mg and 
lithium carbonate 600 mg pe'day. Four days later, 
while taking a routine pulse and blood pressure 
recording, it was noted that his pulse was 88/ 
min and irregularly irregular in rate. He was 
asymptomatic at this time, having no complaint 
of palpitations. A repeat ECG showed a heart 
rate of 104/min and multiple unifocal ventricular 
ectopics (about 24/min). 12 hour serum lithium 
at this time was 0.45 mmol/L. During this time, 
the patient was not on any other medication other 
than lithium and lorazepam. Lithium was 
discontinued while lorazepam was continued. A 
cardiac ECHO done one day later and an ECG 
done two days later were both normal. A Holter 
recording done two weeks later was also normal. 
Five days after stopping lithium, the patient was 
started on carbamazepine and the dose 
increased to 600 mg a day. After one week, 
lorazepam was reduced and stopped. (Two 
weeks after starting carbamazepine its serum 
level was 9.9 ug/ml). The patient recovered 
uneventfully and an ECG done while the patient 
was on carbamazepine was normal. 
During outpatient review, he had an 
exacerbation of asthma but recovered. A repeat 
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ECG was normal and serum carbamazepine 
level was 7.6 ug/ml. At the time of writing this 
report, patient is euthymic and remains well. 
The issue of the patient's irregular pulse 
on lithium was discussed with the patient and 
family members. At this time, his sister, who is a 
nurse, mentioned that about a year ago she had 
taken a routine pulse and blood pressure 
recording on him and remembered that his pulse 
was irregular in rate and blood pressure recording 
was about 120/100 mm. She did suggest that 
he see a doctor about this, but he had refused 
saying that he had no physical complaints. 
Interestingly, when the patient was treated with 
lithium, chlorpromazine and carbamazepine four 
years ago, there was no mention of any 
irregularity in the pulse. 
DISCUSSION 
The most common ECG abnormality due 
to lithium is reversible T wave changes. Demers 
and Heninger (1971) reported T wave 
depression, unrelated to lithium levels in all six 
of his study patients. He noted that a single ECG 
was unlikely to pick up this finding. 
The most clinically significant 
complication of lithium therapy is stated to be 
SA node dysfunction - even when lithium is in 
the therapeutic range (Wellens et al.,1975). 
Rosenquist et al.(1993), reported that depressed 
sinus node dysfunction was significantly more 
in lithium treated patients when compared to age 
matched population. 
Lithium is also known to aggravate 
preexisting cardiac arrhythmias, particularly in 
patients with heart failure in whom renal 
clearance of this ion is impaired (Brunwald, 1997). 
There are very few references to lithium 
induced ventricular arrhythmias. Tangedahl and 
Gau, (1972) reported lithium induced premature 
ventricular contractions (PVCs) in a patient with 
no previous symptoms or evidence of cardiac 
disease. This patient had chest discomfort and 
palpitations (lithium level 0.6 mEq/L). The patient 
recovered when lithium was discontinued. 
Tilkian et al.(1976) assessed the effect of 
long term lithium treatment on cardiac 
arrhythmias and cardiovascular performance on 
12 patients. He found that 11 patients had some 
ventricular arrhythmia but only one had PVCs 
after starting lithium and not before (measured 
by ambulatory ECG monitoring). He also 
remarked that ventricular arrhythmia (PVC, 
couplets and ventricular tachycardia) during 
exercise and in the immediate recovery period 
reduced in three out of four patients during 
lithium therapy (measured by ECG monitoring). 
This conflicting finding in the same group of 
patients was rationalised by the authors as being 
a result of differing methods of testing. They also 
noted that lithium abolished premature atrial 
contractions during exercise in four patients and 
suggested that lithium may be benificial in 
controlling atrial tachycardia. 
In our patient, there is a possibility that he 
had an irregular pulse atleast on one occasion 
in the past (In view of the information 
subsequently obtained from his sister). However, 
at the time of admission to our hospital his pulse 
rate was regular. A therapeutic level of lithium 
resulted in an irregular pulse and ECG 
abnormalities, both of which reverted to normal 
after lithium was stopped. 
In conclusion, in a review of the literature, 
Brady and Horgan (1988) point out that though 
lithium is implicated in a variety of cardiac 
conduction abnormalities, the prevalence and 
clinical significance of cardiac arrhythmias due 
to lithium are still unclear. Most of the published 
literature is based on small number of patients 
and uncontrolled studies. 
It is recommended that repeat ECGs are 
done on high risk patients on lithium 
(Burggraf,1997). As our patient illustrates the 
point that ventricular ectopics can be 
asymptomatic and occur when lithium level is 
well within the therapeutic range, it is important 
to routinely monitor atleast the pulse rate in all 
patients after starting lithium. 
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